Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
About This Webinar
Marketing and business development are often costly for life science companies and among the first expenses to be cut in challenging times.
BioAlliance Strategies and Outbound Pharma created a strategic partnership to enhance Marketing and Business Development activities to generate maximum impact for your organization leveraging technology platforms and traditionally highly valued personal efforts. These combined services create a cost effective model designed to Increase Your BD-ROI.
When a reduction of your sales team is considered, don't lose a chance to communicate to a global audience of 40K+ industry contacts along with a personal touch to build your BD pipeline.
Agenda
- Intro to BioAlliance and Outbound Pharma
- About Presenters
- Calendar
- Newsletters
- Webinars
- Reporting
- Pipeline Build
- Q & A
- Conclusion
Language:
English
Who can attend? Anyone with the event link can attend
Featured Presenters
Founder & Managing Director
James J. Sarene has over 30 years’ experience in the Life Sciences working with companies from emerging biotech to large pharmaceuticals. With special expertise in Business Development, M&A and Licensing, Mr. Sarene was Managing Director at Madison Keats, a boutique Charlotte based transactional firm, where he focused on providing clients with strategic partnerships enabling growth opportunities.
Mr. Sarene also led North American activity as Sr. Director, Business Development for the Indian based clinical research organization CliniRx Research. While at i3 Statprobe, he managed the relationships for Wyeth, Schering-Plough, and GSK along with many smaller biotech and pharmaceutical clients. As an independent consultant in the Life Sciences, Mr. Sarene established relationships for such companies as Lorus Therapeutics, Ockham Development, Maaguzi, eClipse, ERA Clinical, Biovator, OrtoWay, SpringFire Laboratory Network, and between Pheromone & Healthwatch Systems that successfully launched the product OV Watch to the market. Mr. Sarene has a B.A. in Psychology from Youngstown State University.
Mr. Sarene also led North American activity as Sr. Director, Business Development for the Indian based clinical research organization CliniRx Research. While at i3 Statprobe, he managed the relationships for Wyeth, Schering-Plough, and GSK along with many smaller biotech and pharmaceutical clients. As an independent consultant in the Life Sciences, Mr. Sarene established relationships for such companies as Lorus Therapeutics, Ockham Development, Maaguzi, eClipse, ERA Clinical, Biovator, OrtoWay, SpringFire Laboratory Network, and between Pheromone & Healthwatch Systems that successfully launched the product OV Watch to the market. Mr. Sarene has a B.A. in Psychology from Youngstown State University.
Outbound Pharma, Managing Director - Strategic Partner: EU Director, Strategic BD Relations
Dr. Claudio Rota has over 20 years of experience in the life sciences industry, specializing in business development, strategic consulting, and entrepreneurship. As the Founder and Managing Director of Outbound Pharma since 2017, he has spearheaded initiatives that foster growth and forge partnerships in the biopharmaceutical sector, successfully supporting hundreds of clients.
His global clientele includes top 100 pharmaceutical companies, CROs, API manufacturers, CMO/CDMOs, and various service providers. Claudio has led over 120 business development projects worldwide, with a total estimated value surpassing $50M within the biopharma industry.
Prior to founding Outbound Pharma, Claudio held prominent business development roles at Dentsply Sirona, EmPartners, Ardigen, Reckitt Benckiser Pharmaceuticals, and Nanopharma Technologies, among others. He has extensive experience in both the U.S. and global markets, where he led project delivery teams specializing in lead generation, client acquisition, market research, and deal closures—ensuring consistent sales pipeline growth. Claudio is widely recognized as an authority in customer acquisition and new business development.
Claudio earned a Ph.D. and M.S. in Biomedical Engineering from the University of Rochester, a B.S. in Physics from Southern Polytechnic State University, and a Master’s in Fundraising from Bologna Business School at the University of Bologna.
His global clientele includes top 100 pharmaceutical companies, CROs, API manufacturers, CMO/CDMOs, and various service providers. Claudio has led over 120 business development projects worldwide, with a total estimated value surpassing $50M within the biopharma industry.
Prior to founding Outbound Pharma, Claudio held prominent business development roles at Dentsply Sirona, EmPartners, Ardigen, Reckitt Benckiser Pharmaceuticals, and Nanopharma Technologies, among others. He has extensive experience in both the U.S. and global markets, where he led project delivery teams specializing in lead generation, client acquisition, market research, and deal closures—ensuring consistent sales pipeline growth. Claudio is widely recognized as an authority in customer acquisition and new business development.
Claudio earned a Ph.D. and M.S. in Biomedical Engineering from the University of Rochester, a B.S. in Physics from Southern Polytechnic State University, and a Master’s in Fundraising from Bologna Business School at the University of Bologna.
Global Leader of Integrated BD/Marketing
Established in 2011, BioAlliance Strategies is a world leader in creating cost effective and efficient BD/Marketing strategies and programs to the life science industry.
AN INTEGRAATED BD/MARKETING MODEL
BioAlliance Strategies communicates your value and capabilities to our proprietary global database of 40K plus industry contacts and will include your current CRM contacts. Our model is built to coordinate resources and act as a combination of both marketing and business development to maximize your BD-ROI. Our global outreach leverages platforms including newsletters, webinars, videos and social media.
AN INTEGRAATED BD/MARKETING MODEL
BioAlliance Strategies communicates your value and capabilities to our proprietary global database of 40K plus industry contacts and will include your current CRM contacts. Our model is built to coordinate resources and act as a combination of both marketing and business development to maximize your BD-ROI. Our global outreach leverages platforms including newsletters, webinars, videos and social media.
At Outbound Pharma, we understand that business development in the life sciences is about more than just transactions—it’s about building meaningful connections. By helping organizations forge the right partnerships, we aim to make a lasting impact on the future of medicine and, ultimately, on the health and well-being of people around the globe.
FOCUS ON YOUR BUSINESS AS WE BUILD YOUR PIPELINE
Your core business is to bring products and services that improve medicines and expand access to better patient care — you shouldn’t have to focus all your time and resources on generating new business opportunities for your organization.
FOCUS ON YOUR BUSINESS AS WE BUILD YOUR PIPELINE
Your core business is to bring products and services that improve medicines and expand access to better patient care — you shouldn’t have to focus all your time and resources on generating new business opportunities for your organization.
Hosted By
BioAlliance Video Network's Webinars and Video Conferences